Pick of the week DNDN
Morsid,
I have nothing to comment about DNDN, just refer to previous posts and take a closer look at the chart
Tonight will be bargain hunting, buy on pull back. We will never see below $20 next week.
Friday, May 4, 2007
Subscribe to:
Post Comments (Atom)
4 comments:
DNDN support is at 20.10
Good entry price - 20.18 to 20.30
We shall see straight line till 1.30 pm
The big move shall resume after 2 pm
DNDN - closed at 19.39 i guess as we spoke this morning there might be speculators who wanted to bring the price down for them to buy.
I guess we must be little bit smarter in this situation where we should lock in the profit at 21.00 minimum and re-enter again.
Back to closing price don't you as opportunity let's monitor the movement on Monday.
QVDX - There's a new of offering of $3.2 and increase from $3.15 from Battery Venture...just want to monitor...
I was not available yesterday
Reason for DNDN to pull back from $21++ to $18.51 and closed $19.30
1. Propaganda news was released on media-stream that a doctor requesting FDA not to approve DNDN Provenge, that triggered traders panic into selling their shares they are holding. It was discovered later that it was the work of hedge funds by the investors & traders. Do not panic into selling your shares as it was a scam tactics by those who missed the buying opportunity below $18.
2. DNDN share price was running too fast on Friday to $21.80 that could have triggered MM & traders to lock their gains for the week end. They bought thousands of shares last Monday or Tuesday and probably locked 10% to 20% of their holding. Those with small quantity of shares bought below $18; do not have to follow them into panic selling on Friday. The share price of DNDN will not go below $18 next week. I will be looking for more buying on pull back next week.
Value trading and investing
I will monitor and focus more on DNDN next week than other stocks. Wall Street money makers, smart money, institutional investors, broking houses, professional and small time traders have been watching closely and do not want to miss potential gain from DNDN trade. Most successful traders build their capital over the years by trading and investing into value and growth stocks. Upon approval of Provenge by FDA will generate 1 Billion of DNDN sales yearly that will translate share price of DNDN to double, triple or multiple from here.
I will post later in the afternoon of DNDN outlook for next week
Post a Comment